Joint Filing Agreement
Exhibit 99.1
EXHIBIT 1
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the common stock, par value $0.001 per share, of SciClone Pharmaceuticals, Inc., a Delaware Corporation, and further agree that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
[Remainder of this page has been left intentionally blank.]
Signature Page
IN WITNESS WHEREOF, the undersigned hereby execute this Agreement as of the 19th day of November 2012.
|
GL Trade Investment Limited |
/s/ Xxxxxx Xxxxxxx |
|
|
Name: Xxxxxx Xxxxxxx |
|
|
Title: Director |
|
|
|
|
GL China Opportunities Fund L.P. |
/s/ Zhenfu Li |
|
By: GL Capital Management GP L.P. |
Name: Zhenfu Li |
|
Its General Partner |
Title: Chief Executive Officer |
|
|
|
|
GL Capital Management GP L.P. |
/s/ Zhenfu Li |
|
By: GL Capital Management GP Limited |
Name: Zhenfu Li |
|
Its General Partner |
Title: Chief Executive Officer |
|
|
|
|
GL Capital Management GP Limited |
/s/ Zhenfu Li |
|
|
Name: Zhenfu Li |
|
|
Title: Director |
|
|
|
|
GL Partners Capital Management Limited |
/s/ Zhenfu Li |
|
|
Name: Zhenfu Li |
|
|
Title: Director |
|
|
|
|
Zhenfu Li |
/s/ Zhenfu Li |
|
|
Name: Zhenfu Li |
